• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 1.11%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    3.98 Down 0.12(2.93%) May 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.10
    Open:4.06
    Bid:3.95 x 3000
    Ask:4.19 x 100
    1y Target Est:7.00
    Beta:-0.8
    Next Earnings Date:N/A
    Day's Range:3.96 - 4.10
    52wk Range:3.08 - 5.48
    Volume:672,495
    Avg Vol (3m):832,749
    Market Cap:371.99M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUDown 2.93%371.99M
    BIIBDown 1.45%92.42B
    GSKDown 3.14%105.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):86.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback